HYUNDAI BIOLAND Co.Ltd (052260) - Cash Flow Conversion Efficiency
Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.09 Billion ≈ $9.55 Million USD) by net assets (₩137.95 Billion ≈ $93.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 052260 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
HYUNDAI BIOLAND Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
HYUNDAI BIOLAND Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HYUNDAI BIOLAND Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yukselen Celik As
IS:YKSLN
|
0.232x |
|
Can Don Hydro Power JSC
VN:SJD
|
-0.008x |
|
Silver Ridge Holdings Bhd
KLSE:0129
|
-0.033x |
|
GROUP PAREF INH. EO 25
F:G5I
|
N/A |
|
Entropy Neurodynamics Limited
AU:ENP
|
-0.327x |
|
Vintcom Technology PCL
BK:VCOM
|
0.138x |
|
Koss Corporation
NASDAQ:KOSS
|
-0.020x |
|
Bangkok Dec-Con Public Company Limited
BK:BKD
|
-0.006x |
Annual Cash Flow Conversion Efficiency for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is HYUNDAI BIOLAND Co.Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩138.01 Billion ≈ $93.53 Million |
₩4.60 Billion ≈ $3.12 Million |
0.033x | -18.86% |
| 2023-12-31 | ₩135.98 Billion ≈ $92.15 Million |
₩5.59 Billion ≈ $3.79 Million |
0.041x | -53.04% |
| 2022-12-31 | ₩129.29 Billion ≈ $87.62 Million |
₩11.31 Billion ≈ $7.67 Million |
0.087x | -48.93% |
| 2021-12-31 | ₩125.35 Billion ≈ $84.95 Million |
₩21.48 Billion ≈ $14.55 Million |
0.171x | +162.43% |
| 2020-12-31 | ₩137.23 Billion ≈ $93.00 Million |
₩8.96 Billion ≈ $6.07 Million |
0.065x | -10.45% |
| 2019-12-31 | ₩155.72 Billion ≈ $105.53 Million |
₩11.35 Billion ≈ $7.69 Million |
0.073x | -31.58% |
| 2018-12-31 | ₩148.91 Billion ≈ $100.91 Million |
₩15.87 Billion ≈ $10.75 Million |
0.107x | +4.79% |
| 2017-12-31 | ₩137.82 Billion ≈ $93.40 Million |
₩14.01 Billion ≈ $9.50 Million |
0.102x | +3.39% |
| 2016-12-31 | ₩130.53 Billion ≈ $88.46 Million |
₩12.84 Billion ≈ $8.70 Million |
0.098x | +5.23% |
| 2015-12-31 | ₩121.82 Billion ≈ $82.55 Million |
₩11.38 Billion ≈ $7.71 Million |
0.093x | -13.83% |
| 2014-12-31 | ₩114.48 Billion ≈ $77.58 Million |
₩12.42 Billion ≈ $8.41 Million |
0.108x | -32.23% |
| 2013-12-31 | ₩107.40 Billion ≈ $72.78 Million |
₩17.19 Billion ≈ $11.65 Million |
0.160x | +35.42% |
| 2012-12-31 | ₩100.65 Billion ≈ $68.21 Million |
₩11.90 Billion ≈ $8.06 Million |
0.118x | -28.25% |
| 2011-12-31 | ₩93.29 Billion ≈ $63.22 Million |
₩15.37 Billion ≈ $10.41 Million |
0.165x | -- |
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more